Dr Reddy's Lab launches Avigan for COVID-19 treatment
Dr Reddy's Laboratories Ltd announced the launch of Avigan (favipiravir) 200 mg tablets in India for the treatment of patients with mild to moderate COVID-19 disease
Global Pharma | 19/08/2020 | By Darshana | 284
Aurobindo Pharma Q1 net profit rises by 22.8% to Rs. 780.6 crore
Aurobindo Pharma registered a 22.8 per cent year-on-year rise in net profit at Rs. 780.6 crore for the first quarter ended June 2020
Global Pharma | 13/08/2020 | By Darshana | 147
FDA Posts Interim Results from Required Essure Postmarket Surveillance Study
?Although Essure is no longer available for implantation in the U.S., the FDA remains committed to evaluating long-term safety information in women who have received the device, including data from an FDA-required postmarket surveillance study.?
Global Pharma | 10/07/2020 | By Darshana | 173
Today, the U.S. Food and Drug Administration issued warning letters to two breast implant manufacturers for failure to comply with various regulatory requirements
Global Pharma | 15/05/2020 | By Darshana | 195
Merck?s foundational CRISPR-Cas9 technology receives US patnet
Merck, a leading science and technology company, announced that two of its CRISPR-Cas9-assisted genome-editing patents have been allowed in the United States
Global Pharma | 12/05/2020 | By Darshana | 182
The U.S. Food and Drug Administration has issued the first emergency use authorization (EUA) for a COVID-19 antigen test, a new category of tests for use in the ongoing pandemic
Global Pharma | 10/05/2020 | By Darshana | 167
FDA Continues to Combat Fraudulent COVID-19 Medical Products
Today, the U.S. Food and Drug Administration is providing an update on the agency?s efforts to combat the extremely concerning actions by companies and individuals that are exploiting or taking advantage of widespread fear among consumers during the COVID-19 pandemic
Global Pharma | 08/05/2020 | By Darshana | 151
Cleveland Clinic establishes center for global and emerging pathogens research
Cleveland Clinic is establishing the Center for Global and Emerging Pathogens Research to broaden understanding of emerging pathogens ? ranging from Zika virus to SARS-CoV-2 (which causes COVID-19) ? and to expedite critically needed treatments and vaccines
Global Pharma | 04/05/2020 | By Darshana | 173
Revive Therapeutics, a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced that it has received positive feedback from the US Food and Drug Administration (FDA) in response to the company?s Pre-Investigational New Drug (pre-IND) meeting
Global Pharma | 25/04/2020 | By Darshana | 601
Detecting iron deficiency early during pregnancy and in young children is crucial. Iron deficiency in children under two years of age can have significant and irreversible effects on brain development. This can lead to negative consequences on learning and school performance later in life
Global Pharma | 22/04/2020 | By Darshana | 148
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy